Hailing Liu

653 total citations
23 papers, 510 citations indexed

About

Hailing Liu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Hailing Liu has authored 23 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Hailing Liu's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Hailing Liu is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Hailing Liu collaborates with scholars based in China, United States and Singapore. Hailing Liu's co-authors include Bei Zhang, Hui Zhu, Qingbing Wang, Mark J. Czaja, Brett Jones, Karen L. Valentino, Anu Srinivasan, Konrad L. Streetz, Dennis R. Koop and Ji Ma and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Hepatology.

In The Last Decade

Hailing Liu

17 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hailing Liu China 9 238 165 145 74 62 23 510
Saijun Fan China 11 120 0.5× 61 0.4× 257 1.8× 66 0.9× 42 0.7× 32 581
Marta Duran‐Güell Spain 14 271 1.1× 166 1.0× 151 1.0× 10 0.1× 46 0.7× 20 558
Roger Flores‐Costa Spain 13 264 1.1× 159 1.0× 168 1.2× 9 0.1× 44 0.7× 19 581
Kan Toriguchi Japan 10 132 0.6× 98 0.6× 137 0.9× 11 0.1× 50 0.8× 27 374
Nancy W. Bethea United States 13 174 0.7× 305 1.8× 151 1.0× 17 0.2× 243 3.9× 14 684
Eszter Trojnár United States 11 234 1.0× 142 0.9× 164 1.1× 13 0.2× 40 0.6× 16 647
Mengli Yu China 12 140 0.6× 32 0.2× 163 1.1× 23 0.3× 27 0.4× 23 473
Omar Motiño Spain 16 168 0.7× 70 0.4× 253 1.7× 12 0.2× 24 0.4× 31 561
Isabel Veloso Alves Pereira Brazil 16 250 1.1× 100 0.6× 322 2.2× 8 0.1× 40 0.6× 34 601

Countries citing papers authored by Hailing Liu

Since Specialization
Citations

This map shows the geographic impact of Hailing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailing Liu more than expected).

Fields of papers citing papers by Hailing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailing Liu. The network helps show where Hailing Liu may publish in the future.

Co-authorship network of co-authors of Hailing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hailing Liu. A scholar is included among the top collaborators of Hailing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailing Liu. Hailing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng, Lixia, Hailing Liu, Xiaohui Zhang, et al.. (2025). Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma. Blood Cancer Journal. 15(1). 81–81. 2 indexed citations
2.
3.
4.
Wu, Bing, Junpei Zhang, Ying Chen, Shiyao Chen, & Hailing Liu. (2024). Association between non-alcoholic fatty liver disease and the risk of pulmonary nodules in patients with intestinal polyps. Journal of Thoracic Disease. 16(6). 3990–3999.
5.
Zhang, Junpei, et al.. (2024). Dendrobine alleviates oleic acid-induced lipid accumulation by inhibiting FOS/METTL14 pathway. Journal of Molecular Histology. 55(5). 995–1007. 3 indexed citations
6.
Ding, Kaiyang, Hailing Liu, Lixia Sheng, et al.. (2024). Anti-PD-1 antibody (Tislelizumab) combined with gemcitabine and oxaliplatin for extranodal NK/T-cell lymphoma failing asparaginase: A multicenter phase II trial. European Journal of Cancer. 214. 115155–115155.
7.
Wang, Yan, Hailing Liu, Hui Wang, et al.. (2023). Enhancing morphological analysis of peripheral blood cells in chronic lymphocytic leukemia with an artificial intelligence-based tool. Leukemia Research. 130. 107310–107310.
8.
9.
Liu, Hailing, Bin Deng, Yonghua Chen, et al.. (2022). QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study. EClinicalMedicine. 52. 101615–101615. 17 indexed citations
10.
Li, Shanshan, Xiaohui Zhai, Hailing Liu, et al.. (2022). Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Experimental Hematology and Oncology. 11(1). 71–71. 8 indexed citations
11.
Pang, Xiaolin, Liang Huang, Yan Ma, et al.. (2021). Management of Clinically Involved Lateral Lymph Node Metastasis in Locally Advanced Rectal Cancer: A Radiation Dose Escalation Study. Frontiers in Oncology. 11. 674253–674253. 3 indexed citations
12.
Zhang, Junpei, Yin Chen, Yi Tian, Shiyao Chen, & Hailing Liu. (2021). Knockdown of TRIM15 inhibits the activation of hepatic stellate cells. Journal of Molecular Histology. 52(4). 839–848. 5 indexed citations
13.
Ding, Kaiyang, Hailing Liu, Haiyan Yang, et al.. (2021). Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial. Blood. 138(Supplement 1). 1385–1385.
14.
Huang, Yan, Xiaoying Lou, Yaxi Zhu, et al.. (2019). Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer. Bioscience Reports. 39(3). 13 indexed citations
15.
Zhang, Fan, Li Cui, Hailing Liu, et al.. (2014). The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells. Tumor Biology. 35(12). 12379–12387. 6 indexed citations
16.
Wang, Qingbing, Hui Zhu, Hailing Liu, & Bei Zhang. (2012). Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology. 56(1). 239–247. 194 indexed citations
17.
Ma, Ji, et al.. (2011). Interactions of Flavonoids with Biomacromolecules. Current Organic Chemistry. 15(15). 2627–2640. 21 indexed citations
18.
Jones, Brett, et al.. (2002). Cytochrome P450 2E1 Expression Induces Hepatocyte Resistance to Cell Death from Oxidative Stress. Antioxidants and Redox Signaling. 4(5). 701–709. 28 indexed citations
19.
Jones, Brett, et al.. (2000). Role of caspases and NF-κB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 278(5). G693–G699. 81 indexed citations
20.
Jones, Brett, Hailing Liu, Anu Srinivasan, et al.. (2000). Hepatocytes Sensitized to Tumor Necrosis Factor-α Cytotoxicity Undergo Apoptosis through Caspase-dependent and Caspase-independent Pathways. Journal of Biological Chemistry. 275(1). 705–712. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saijun Fan Breakdown of academic impact, for papers by Marta Duran‐Güell Breakdown of academic impact, for papers by Roger Flores‐Costa Breakdown of academic impact, for papers by Kan Toriguchi Breakdown of academic impact, for papers by Nancy W. Bethea Breakdown of academic impact, for papers by Eszter Trojnár Breakdown of academic impact, for papers by Mengli Yu Breakdown of academic impact, for papers by Omar Motiño Breakdown of academic impact, for papers by Isabel Veloso Alves Pereira
Rankless by CCL
2026